Jessie J F Medeiros

9PUBLICATIONS
61CO-AUTHORS
Molecular targetsHaematological tumoursRespiratory diseasesPredictive and prognostic markersCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 30, 2026
The adverse prognostic impact of HMGCLL1 gene variants can be abrogated by frontline second-generation tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.

Maria Agustina Perusini, Katia Pagnano, Carolina Pavlovsky

|Feb 02, 2026
JAK2V617F reprograms Hypoxia Inducible Factor-1 to induce a non-canonical hypoxia regulon in myeloproliferative neoplasms.

David Kealy, Ruth Ellerington, Suraj Bansal

|Jan 02, 2026
A stem and progenitor cell-derived gene expression signature is prognostic for survival in myelofibrosis.

Jessie J F Medeiros, Andy G X Zeng, Suraj Bansal

|Mar 06, 2024
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.

Maria Agustina Perusini, Daniela Žáčková, Taehyung Kim

|Sep 10, 2022
Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma.

Tracy Lackraj, Sharon Ben Barouch, Jessie J F Medeiros

|Aug 16, 2022
Clonal hematopoiesis confers an increased mortality risk in orthotopic heart transplant recipients.

Fernando L Scolari, Darshan H Brahmbhatt, Sagi Abelson

Pageof 2

Frequent Collaborators

4 joint publications

Sagi Abelson

3 joint publications

John E Dick

2 joint publications

Darshan H Brahmbhatt

2 joint publications

Stefan Anker